openPR Logo
Press release

Prefilled Auto Injectors Market Covering Growth Inclinations & Development Strategies until 2022 | Major Players - Becton, Dickinson and Company, Pfizer , Mylan N.V., Antares Pharma, Amgen Inc

02-22-2019 10:33 AM CET | Health & Medicine

Press release from: Fact.MR

Prefilled Auto Injectors Market Covering Growth Inclinations &

Growing preference for convenient injection of anticoagulants and the introduction of a spectrum of new biotech products is reflecting favorably on the global prefilled auto-injectors market. Over the next couple of years, use of prefilled auto-injectors is expected become widespread across the globe. The product has made self-inject procedures extremely convenient for patients, hence, gaining a significant amount of user trust. In addition, the next generation prefilled auto injectors are more advanced in terms of technology and design. Manufacturers are actively focusing on perfecting prefilled auto-injectors in order to facilitate their use in new therapeutic areas.  Prefilled auto-injectors are essentially developed for more reliable and accurate injection. Factors as such are anticipated to further boost the global sales of prefilled auto-injectors. According to the recent study conducted by Fact.MR, the global prefilled auto injectors market is set to ride at a double-digit CAGR during 2017 to 2022, to reach a valuation in excess of US$ 3,616 Mn

Get Sample of this research report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=169

Prefilled auto-injectors are primarily intended for self-administration by patients without the obligation of any special training. These injectors come with standard prefilled barrels that contain therapeutic drugs and are easy to use. By design, they are mostly compact and have a pen like shape with a tiny reusable needle attached on the nip. Usually, the site of injection is either thighs or arms, but it may differ on a case-by-case basis or dosage of drug.

North America Will Continue to Spearhead the Global Prefilled Auto-Injectors Market

In terms of revenue, North America is expected to dominate the global prefilled auto-injectors market over 2022. This is primarily owing to the rising number of patients who require drug administration on regular basis. Owing to the extreme convenience of administrating insulin, prefilled auto injectors are also gaining popularity among patients suffering from diabetes in the region. The prefilled auto injectors market in North America in expected to witness a strong growth over the forecast period. Meanwhile, robust development of the healthcare sector coupled with low cost of prefilled auto-injectors is proving to be instrumental for the growth of the market in Asia-Pacific excluding Japan (APEJ). Between 2017 and 2022, the region’s market is projected to increase at an impressive CAGR of 15.9%.

Browse More Information about this Report @ https://www.factmr.com/report/169/prefilled-auto-injectors-market

Based on indication, the anaphylaxis segment currently accounts for more than two-third revenue share of the market. The segment is estimated to reach a market valuation of over US$ 3,187 Mn towards the end of 2022, reflecting a strong CAGR. In addition, the segment is expected to growing at around US$ 320 Mn annually over the course of the assessment period.

Competition Tracking

Fact.MR’s report also profiled companies that are expected to remain active in the expansion of global prefilled auto injectors market through 2022, which include Becton, Dickinson and Company, Pfizer Inc., Mylan N.V., Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.

Make an Enquiry before buying this report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=169

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us            
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prefilled Auto Injectors Market Covering Growth Inclinations & Development Strategies until 2022 | Major Players - Becton, Dickinson and Company, Pfizer , Mylan N.V., Antares Pharma, Amgen Inc here

News-ID: 1609657 • Views:

More Releases from Fact.MR

Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2034 | Key players: Pfizer Inc., F. Hoffman-La Roche Ltd., Sanofi S.A., and Seattle Genetics, and Genentech.
10-03-2025 | Health & Medicine
Fact.MR
Triple Negative Breast Cancer Treatment Market is Growing at a CAGR of 4.6% by 2 …
Fact.MR today unveiled its latest report on the Triple Negative Breast Cancer Treatment Market, projecting steady yet impactful growth amid rising global breast cancer incidences and a push for innovative therapies targeting this aggressive subtype. Valued at USD 670.5 million in 2024, the global market is forecasted to expand at a compound annual growth rate (CAGR) of 4.6%, reaching USD 1.04 billion by 2034. This expansion underscores the urgent need
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, Led by Roche, Boehringer Ingelheim & Others
10-03-2025 | Health & Medicine
Fact.MR
Pulmonary Fibrosis Treatment Market: U.S. to Grow to US$ 4.06 Billion by 2034, L …
The global pulmonary fibrosis treatment market is poised for steady expansion, with its valuation projected to grow from USD 3,210 million in 2025 to USD 5,890 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 6.2% over the forecast period from 2025 to 2035. The surge is primarily driven by the increasing prevalence of idiopathic pulmonary fibrosis (IPF), rising awareness of early diagnosis, and advancements in
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | McCormick & Company, Associated British Foods, Olam International, Sensient Technologies, Kerry Group
10-03-2025 | Food & Beverage
Fact.MR
Spices and Seasonings Market is Projected to Reach USD 23.6 Billion by 2035 | Mc …
The global spices and seasonings market is set for significant growth, projected to expand from USD 14.5 billion in 2025 to USD 23.6 billion by 2035, achieving an absolute increase of USD 8.3 billion and a 57.2% overall growth. This trajectory reflects a compound annual growth rate (CAGR) of 5.0% over the forecast period from 2025 to 2035, representing a 1.57X market size increase. The expansion is driven by rising
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% CAGR, Supported by PwC, EY, Deloitte & KPMG
Accounting Services Market: U.S. to Grow to US$ 640.73 Billion by 2034 at 10.3% …
The global accounting services market is positioned for substantial growth, with its valuation projected to increase from USD 650 billion in 2025 to USD 1,250 billion by 2035. This expansion reflects a compound annual growth rate (CAGR) of 6.7% over the forecast period from 2025 to 2035. The market's surge is driven by the increasing complexity of financial regulations, the digital transformation of businesses, and the rising demand for outsourced

All 5 Releases


More Releases for Prefilled

Global Prefilled Syringes Market by Material (Glass Prefilled Syringes, and Plas …
The global prefilled syringes market size is anticipated to reach USD 10.5 billion by 2028, at a CAGR of 8.5% during the forecast period due to the high prevalence of chronic diseases and the rising adoption of self-injection devices. Global prefilled syringes market estimated to grow with a CAGR of 8.5% during the forecast period, 2021-2028. It is owing to the benefits of prefilled syringes such as the low risk of
Benefits of Prefilled Syringes over Traditional Vials and Syringes Driving Prefi …
In 2017, the global prefilled syringes market reached $4.7 billion and is projected to register an 8.3% CAGR during the forecast period (2018-2023). The market is growing because of the extensive pipeline of injectable drugs, rising demand for injectable pharmaceutical products, expanding pharmaceutical industry, increasing prevalence of chronic and lifestyle associated diseases, surging requirement for point-of-care administration, benefits of prefilled syringes over conventional vial and syringe packaging systems, regulations associated
07-23-2019 | Health & Medicine
Factmr
Prefilled Syringes Market - Increasing Use of Glass Prefilled Syringes to Aid th …
With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. Given the advantages of standalone drug injecting systems such as prefilled syringes, such as ease in use and enhanced safety, their demand is expected to increase at a high pace in the coming years. For more incisive insights, Request a Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=603 According to Fact.MR analysis on prefilled syringes,
Development Of Technologically Advanced Prefilled Syringes Is Expected To Boost …
Small molecule prefilled syringes are pharmaceutical preparations of small molecule drugs that are sold in prefilled syringes. Small molecule prefilled syringes are alternatives to other dosage forms such as tablets and capsules. Empty glass or plastic and polymer syringes are filled with the solution of the active pharmaceutical ingredients. Drugs belonging to categories such as cardiovascular, analgesics, neurology, and adjuvants are offered in prefilled syringe delivery systems. Small molecule prefilled
Prefilled Safety Devices Market – Latest Advancements
Prefilled Safety Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Prefilled Safety Devices market research report is a professional and in-depth study on the current state of Prefilled Safety Devices Industry. The Prefilled Safety Devices Market research report covers the present scenario and
Prefilled Syringes Market
Parenteral drugs are the second most preferred type of drugs after oral solid dosage forms and also holds second largest market share in terms of revenue in overall pharmaceutical market. Various benefits such as ease in administration, better patient compliance and 100% bioavailability are the few important factors that are expected to favor growth of the prefilled syringes market over the forecast period (2016–2024). Prefilled syringes segment is the one